NEW YORK (GenomeWeb News) – NuGen Technologies and Advanced Liquid Logic today announced an exclusive co-development and supply agreement for commercialization of Advanced Liquid's instrumentation, software, and digital microfluidic cartridge technology.
The companies also are collaborating with the Broad Institute on method development on the digital microfluidic cartridge.
Advanced Liquid's benchtop system enables "direct electrical manipulation of sub-microliter droplets without requiring pumps, valves, or channels," the firms said in a statement. NuGen will market the system under the Mondrian SP brand name.
The initial commercialization target will be next-generation sequencing library preparation protocols, which are being co-developed with the Broad Institute, for Illumina sequencing platforms. The technology will also be developed for NuGen's Ovation RNA-Seq and Encore Amplification Free NGS Library Systems, and those products are expected to become available by the end of the year.
Financial and other terms of the deal were not disclosed.
NuGen CEO Elizabeth Hutt said her firm has provided researchers capabilities to work with very small amounts of starting materials, and "[i]ntroduction of this system is a natural extension of that mission, as the system allows for even smaller amounts of starting materials by working in volumes unachievable with any other existing technologies."
Based in San Carlos, Calif., NuGen develops sample preparation solutions for RNA and DNA. Advanced Liquid is based in Research Triangle Park, NC, and develops digital microfluidic technologies.